CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease-Reference-Cited by-同舟云学术

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington’s Disease

Published:2017-04-02 Issue:4 Volume:18 Page:754
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Kolli Nivya,Lu Ming,Maiti Panchanan,Rossignol Julien,Dunbar Gary

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/18/4/754/pdf

Reference44 articles.

1. Depression and Stages of Huntington’s Disease

2. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

3. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length

4. Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

5. An evidence-based approach in the treatment of Huntington’s disease

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders;Current Gene Therapy;2025-02

2. Global huntingtin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas;Life Science Alliance;2024-07-25

3. Gene editing therapy for cardiovascular diseases;MedComm;2024-07

4. Reviewing the Structure–Function Paradigm in Polyglutamine Disorders: A Synergistic Perspective on Theoretical and Experimental Approaches;International Journal of Molecular Sciences;2024-06-20

5. In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-22